Intermedical Care and Lab Hospital Public Company Limited

SET:IMH-R Stock Report

Market Cap: ฿1.0b

Intermedical Care and Lab Hospital Past Earnings Performance

Past criteria checks 0/6

Intermedical Care and Lab Hospital has been growing earnings at an average annual rate of 2.6%, while the Healthcare industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 17.4% per year.

Key information

2.6%

Earnings growth rate

2.3%

EPS growth rate

Healthcare Industry Growth23.6%
Revenue growth rate17.4%
Return on equity-4.0%
Net Margin-4.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Intermedical Care and Lab Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SET:IMH-R Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24800-331910
30 Jun 24771-361870
31 Mar 24731-71850
31 Dec 23677211790
30 Sep 23518-71410
30 Jun 23499531210
31 Mar 23528961200
31 Dec 226511731240
30 Sep 229063591160
30 Jun 221,1385251200
31 Mar 221,1635441150
31 Dec 219534231060
30 Sep 217272901000
30 Jun 2141585920
31 Mar 21233-24850
31 Dec 20243-17780
30 Sep 20253-20780
30 Jun 20274-21800
31 Mar 2034516860
31 Dec 1933610870
30 Sep 1932511870
31 Dec 1832214850
30 Sep 1831517830
31 Dec 1727515850
31 Dec 1629038820
31 Dec 1521446720

Quality Earnings: IMH-R is currently unprofitable.

Growing Profit Margin: IMH-R is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: IMH-R is unprofitable, but has reduced losses over the past 5 years at a rate of 2.6% per year.

Accelerating Growth: Unable to compare IMH-R's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IMH-R is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8.5%).

Return on Equity

High ROE: IMH-R has a negative Return on Equity (-4.03%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 02:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Intermedical Care and Lab Hospital Public Company Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thakol BanjongruckYuanta Securities (Thailand) Company Limited